Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will provide the names of the experts who were consulted on the Government’s decision, announced on 12 August 2022, not to purchase any doses of Evusheld at this time.

This decision is based on independent clinical advice by multi-agency RAPID C-19 group and a national expert policy working group and reflects the epidemiological context and policies in the Government’s pandemic response and recovery. The National Health Service had overall responsibility for establishing RAPID C-19 and the National Institute for Health and Care Excellence chairs the senior RAPID C-19 Group and provides secretariat support.

Information on the bodies participating in RAPID C-19 is available at the following link:

https://www.nice.org.uk/covid-19/rapid-c19

A list of the individual members of RAPID C-19 is attached.